Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$914.37 8.99 (0.99%) as of 4:30 Mon 7/1


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 874.67(B)
Last Volume: 2,545,641 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,771,329 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 50 93
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1436
  Page 55 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Runge Marschall S Director   –       •      –    2014-11-28 4 A $67.29 $145,010 D/D 2,155 3,125     -
   Oberhelman Douglas R Director   –       •      –    2014-11-28 4 A $67.29 $145,010 D/D 2,155 22,675     -
   Seifert Kathi P Director   –       •      –    2014-11-28 4 A $67.29 $145,010 D/D 2,155 57,913     -
   Prendergast Franklyn G Director   –       •      –    2014-11-28 4 A $67.29 $145,010 D/D 2,155 59,810     -
   Kaelin William G Jr Director   –       •      –    2014-11-28 4 A $67.29 $145,010 D/D 2,155 6,978     -
   Horn Karen N Director   –       •      –    2014-11-28 4 A $67.29 $145,010 D/D 2,155 69,584     -
   Hoover R David Director   –       •      –    2014-11-28 4 A $67.29 $145,010 D/D 2,155 28,108     -
   Fyrwald J Erik Director   –       •      –    2014-11-28 4 A $67.29 $145,010 D/D 2,155 47,982     -
   Baicker Katherine Director   –       •      –    2014-11-28 4 A $67.29 $145,010 D/D 2,155 8,343     -
   Alvarez Ralph Director   –       •      –    2014-11-28 4 A $67.29 $153,556 D/D 2,282 26,282     -
   Simmons Jeffrey N SVP&Pres. Elanco Animal Health   •       –      –    2014-11-19 4 D $67.78 $1,121,623 D/D (16,548) 79,436     -
   Simmons Jeffrey N SVP&Pres. Elanco Animal Health   •       –      –    2014-11-19 4 OE $55.65 $1,038,943 D/D 18,576 88,188     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2014-11-14 5 GD $0.00 $0 D/D 785 528,850     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-11-13 4 S $67.73 $13,546,000 D/D (200,000) 131,775,804     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2014-11-11 4 S $68.49 $51,368 D/D (750) 3,047     -
   Zulueta Alfonso G SVP& Pres., Emerging Markets   •       –      –    2014-11-07 4 D $66.96 $1,289,248 D/D (19,254) 41,160     -
   Zulueta Alfonso G SVP& Pres., Emerging Markets   •       –      –    2014-11-07 4 OE $55.65 $1,185,456 D/D 21,302 60,414     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-11-05 4 S $67.00 $12,060,000 D/D (180,000) 131,975,804     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2014-11-04 4 S $67.00 $1,005,000 D/D (15,000) 26,493     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2014-11-03 4 AS $66.03 $330,150 D/D (5,000) 72,736     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2014-10-31 4 S $66.58 $491,094 I/I (7,376) 14,209     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2014-10-31 4 D $66.80 $199,999 I/I (2,994) 21,585     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2014-10-31 4 OE $55.65 $612,217 I/I 10,951 24,579     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2014-10-31 4 D $66.80 $583,765 D/D (8,739) 41,493     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2014-10-31 4 OE $55.65 $533,461 D/D 9,586 50,232     -
  1436 Records found
  Previous  50  51  52  53  54  55  56  57  58   
  Page 55 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us